Transverse Abdominis Plane (TAP) Block Versus Transversalis Fascia Plane Block (TFPB) After Cesarean Delivery

NCT ID: NCT06939725

Last Updated: 2025-04-30

Basic Information

• Recruitment Status: COMPLETED
• Total Enrollment: 67 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2025-01-01
• Study Completion Date: 2025-03-31

Brief Summary

Postoperative analgesia treatment methods are applied to the living in the operating room. It is a routine part of the process of these applications. It is necessary from medical and ethical perspectives. Postoperative analgesia applications are started in the preoperative period and continue in the postoperative period. The analgesic treatment to be used is shaped according to the application and experience of the anesthesiologist. The scientifically accepted developed method is multimodal analgesia protocols. These protocols cover a wide range from paracetamol to opioids, peripheral and central blocks (such as Transversalis Fascial Plane Block (TFPB) and Transversus Abdominis Plane (TAP) Block). The aim of this study is to continue the analgesia protocols applied in cesarean section surgeries on the first 24-hour pain scores, the amount of opioid consumed after surgery and the quality of obstetric recovery (ObsQoR-10) scale.

Detailed Description

Postoperative analgesia treatment methods are applied to the living in the operating room. It is a routine part of the process of these applications. It is necessary from medical and ethical perspectives. Postoperative analgesia applications are started in the preoperative period and continue in the postoperative period. The analgesic treatment to be used is shaped according to the application and experience of the anesthesiologist. The scientifically accepted developed method is multimodal analgesia protocols. These protocols cover a wide range from paracetamol to opioids, peripheral and central blocks (such as Transversalis Fascial Plane Block (TFPB) and Transversus Abdominis Plane (TAP) Block). In this study, transversus abdominis plane block or transversalis fascial plane block was applied to the participants immediately after surgery. The aim is to continue the analgesia protocols applied to the cesarean section surgeries on the pain scores in the first 24 hours, the amount of opioid consumed after surgery and the quality of obstetric recovery (ObsQoR-10) scale.

Conditions

Acute Pain Management; Caesarean Section

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: PROSPECTIVE

Study Groups

Group 1

Transversus abdominis plane block was performed immediately after cesarean section.

Transversus abdominis plane (TAP) block

Intervention Type: OTHER

We apply different nerve blocks to patients for pain relief after cesarean surgery. Transversus abdominis plane block was applied to this group

Group 2

Transversalis fascial plane block was performed immediately after cesarean section

Transversalis Fascia Plane Block

Intervention Type: OTHER

We apply different nerve blocks to patients for pain relief after cesarean surgery. Transversalis Fascia Plane Block was applied to this group

Interventions

Transversus abdominis plane (TAP) block

We apply different nerve blocks to patients for pain relief after cesarean surgery. Transversus abdominis plane block was applied to this group

Intervention Type: OTHER

Transversalis Fascia Plane Block

We apply different nerve blocks to patients for pain relief after cesarean surgery. Transversalis Fascia Plane Block was applied to this group

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

1. >18 years

2. Term pregnancies (37-42 weeks) and those planned to undergo elective cesarean delivery under spinal anesthesia

Exclusion Criteria

1. <18 years

2. Emergency surgery

3. BMI > 35 kg/m2 or anatomic conditions that would preclude spinal anesthesia

4. Increased susceptibility to bleeding or coagulation disorders (platelet count below 80,000× 10^3/mm^3 or INR > 1.5)

5. Known allergy to any drug, such as local anesthetics, opioids, or NSAIDs

6. Other relevant maternal or neonatal clinical conditions requiring treatment and at the discretion of the investigators, such as gestational hypertension, impaired renal or hepatic function, postpartum hemorrhage

7. Chronic pain conditions and concomitant use of analgesics

• Minimum Eligible Age: 18 Years
• Eligible Sex: FEMALE
• Accepts Healthy Volunteers: No

Sponsors

Samsun University

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

SEVDA AKDENIZ, Assoc Prof

Role: PRINCIPAL_INVESTIGATOR

Samsun University

HATİCE SELÇUK KUŞDERCİ, Asst. Prof.

Role: STUDY_DIRECTOR

Samsun University

Locations

Samsun University, Training and Research Hospital

Samsun, İ̇lkadim, Turkey (Türkiye)

Countries

Turkey (Türkiye)

Other Identifiers

GOKAEK 2024/22/14

Identifier Type: -

Identifier Source: org_study_id